Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;103(4):1092-1100.
doi: 10.1016/j.athoracsur.2016.09.108. Epub 2017 Jan 18.

Nationwide Assessment of Robotic Lobectomy for Non-Small Cell Lung Cancer

Affiliations

Nationwide Assessment of Robotic Lobectomy for Non-Small Cell Lung Cancer

Ravi Rajaram et al. Ann Thorac Surg. 2017 Apr.

Abstract

Background: Robotic lobectomy has been described for non-small cell lung cancer (NSCLC). Our objectives were to (1) evaluate the use of robotic lobectomy over time, (2) identify factors associated with its use, and (3) assess outcomes after robotic lobectomy compared with other surgical approaches.

Methods: Stage I to IIIA NSCLC patients were identified from the National Cancer Data Base (2010 to 2012). Trends in robotic lobectomy were assessed over time, and multivariable logistic regression models were developed to identify factors associated with its use. Propensity-matched cohorts were constructed to compare postoperative outcomes after robotic lobectomy with thoracoscopic and open lobectomy.

Results: Lobectomy was performed in 62,206 patients by open (n = 45,527), thoracoscopic (n = 12,990), or robotic (n = 3,689) procedures at 1,215 hospitals. Between 2010 and 2012, robotic lobectomy significantly increased, from 3.0% to 9.1% (p < 0.001). Academic (odds ratio, 1.55; 95% confidence interval, 1.04 to 2.33) and high-volume hospitals (odds ratio, 1.49; 95% confidence interval, 1.04 to 2.14) were associated with increased use of robotic lobectomy. Length of stay was shorter in robotic lobectomy compared with open lobectomy (6.1 vs 6.9 days; p < 0.001). Fewer lymph nodes (9.9 vs 10.9; p < 0.001) and 12 or more nodes were examined less frequently (32.0% vs 35.6%; p = 0.005) in robotic resections than in thoracoscopic resections. There was no difference between robotic and open or robotic and thoracoscopic lobectomy patients in margin positivity, 30-day readmission, and deaths at 30 and 90 days.

Conclusions: Robotic lobectomies have significantly increased in stage I to IIIA NSCLC patients, with outcomes similar to other approaches. Additional studies are needed to determine if this technology offers potential advantages compared with video-assisted thoracoscopic operations.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Use of open, video-assisted thoracic surgery (VATS), and robotic lobectomy (2010 to 2012).*Significant increase in robotic lobectomy from 3.0% to 9.1% between 2010 and 2012 (p < 0.001).

Comment in

  • Reply.
    Rajaram R, DeCamp MM. Rajaram R, et al. Ann Thorac Surg. 2018 Jan;105(1):337-338. doi: 10.1016/j.athoracsur.2017.03.024. Ann Thorac Surg. 2018. PMID: 29233346 No abstract available.
  • Finding Value in the National Cancer Database: The Robotic Experience.
    Lazar JF. Lazar JF. Ann Thorac Surg. 2018 Jan;105(1):337. doi: 10.1016/j.athoracsur.2017.02.059. Ann Thorac Surg. 2018. PMID: 29233347 No abstract available.

References

    1. Adams RD, Bolton WD, Stephenson JE, Henry G, Robbins ET, Sommers E. Initial multicenter community robotic lobectomy experience: comparisons to a national database. Ann Thorac Surg 2014;97:1893–8; discussion 1899–900. - PubMed
    1. Cerfolio RJ, Bryant AS, Minnich DJ. Starting a robotic program in general thoracic surgery: why, how, and lessons learned. Ann Thorac Surg 2011;91:1729–37. - PubMed
    1. Kent M, Wang T, Whyte R, Curran T, Flores R, Gangadharan S. Open, video-assisted thoracic surgery, and robotic lobectomy: review of a national database. Ann Thorac Surg 2014;97:236–42; discussion 242–4. - PubMed
    1. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl): e278S–313S. - PubMed
    1. Phillips JD, Merkow RP, Sherman KL, DeCamp MM, Bentrem DJ, Bilimoria KY. Factors affecting selection of operative approach and subsequent short-term outcomes after anatomic resection for lung cancer. J Am Coll Surg 2012;215:206–15. - PubMed